Article Details
Retrieved on: 2024-10-14 15:16:29
Tags for this article:
Click the tags to see associated articles and topics
Summary
Spyre Therapeutics, a biotech company, is advancing treatments for inflammatory bowel diseases like Crohn's and ulcerative colitis using monoclonal antibodies. Significant scientific progress and strategic developments bolster its positioning in the biotechnology market.
Article found on: www.investing.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here